维普期刊资源整合服务平台（V6.5）

90篇 您的检索式：作者名="Schellhammer PF"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine 显示文摘	Vlahou A Schellhammer PF	2001	Am J Pathol2001，158，4：	1
2	Prostate specific antigen decreases after withdrawal of antiandrogen therapy with bicalutamide or flutamide in patients receiving combined androgen blockade显示文摘	SCHELLHAMMER PF VENNER P HAAS GP	1997	J Urol1997，157，5：	1
3	Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine显示文摘	Vlahou A Schellhammer PF Mendrinos S	2001	Am J Pathol2001，158，：	1
4	Comparison of guserelin and Leuprolide in Combined androgen blockage therapy显示文摘	Sarosdy MF Schellhammer PF Sharifi R	1998	Urology1998，52，1：	1
5	Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine显示文摘	Vlahou A Schellhammer PF Mendrinos S	2001	Am J Pathol2001，158，4：	1
6	Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine显示文摘	Vlahou A Schellhammer PF Medrinos S	2001	Am J Pathol2001，158，：	1
7	An evaluation of bicalutamide in the treatment of prostate cancerl显示文摘	Schellhammer PF Davis JW	2004	Clin Prostate Cancer2004，2，4：	1
8	Prostate specific antigen decreases after withdrawal of antiandrogen therapy with bicalutamide or flutamide in patients receiving combined androgen blockade显示文摘	SCHELLHAMMER PF VENNER P HAAS GP	1997	J Urol1997，157，5：	1
9	An evaluation of bicalutamide in the treatment of prostate cancer显示文摘	Schellhammer PF Davis JW	2004	Clin Prostate Cancer2004，2，4：	1
10	Integrated data from 2 randomized, double - blind, placebo - controlled, phase 3 trials of active cellular immunotherapy with sipuleucel - T in ad- vanced prostate cancer 显示文摘	Higano CS Schellhammer PF Small E J	2009	Cancer2009，115，16：	1
11	Lower baseline prostate - specific antigen is associated with a greater overall sur- vival benefit from sipuleucel - T in the Immunotherapy for Pros- tate Adenocarcinoma Treatment (IMPACT) trial 显示文摘	Schellhammer PF Chodak G Whitmore JB	2013	Urology2013，81，6：	1
12	Place bo-controlled Phase Ⅲ Trial of immunologic therapy with Sipuleucel-T (APC8015) in patients with metastatic,asymptomatic hormone refractory prostate cancer显示文摘	SMALL E SCHELLHAMMER PF HIGANO Cs	2006	J Clin Oncol2006，24，19：	1
13	Placebo-controlledphaseⅢtrial of immunologic therapy with sipuleucel-T(APC8015)in patients with metastatic,asymptomatic hormone re-fractory prostate cancer显示文摘	Small EJ Schellhammer PF Higano CS	2006	J Clin Oncol2006，24，19：	1
14	Prostate-specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer显示文摘	Kuban DA El-Mahdi AM Schellhammer PF	1995	Int J Radiat Oncol Biol Phys1995，32，：	1
15	Venous thromboembolism显示文摘	Brenner DW Fogle MA Schellhammer PF	1989	J Urol1989，142，：	1
16	Placebo-controlled phase Ⅲ trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer 显示文摘	Small E J Schellhammer PF Higano CS	2006	J Clin Oncol2006，24，19：	1
17	Placebo-controlled phase Ⅲ trial of immunologic therapy with sipuleucel-T(APC8015) in patients with metastatic,asymptomatic hormone refractory prostate cancer显示文摘	Small EJ Schellhammer PF Higano CS	2006	J Clin Oncol2006，24，19：	1
18	Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine 显示文摘	Vlahou A Schellhammer PF Mendrinos S	2001	Am J Pathol2001，158，4：	1
19	Placebo-controlled phase Ⅲ trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic,asymptomatic hormone refractory prostate cancer显示文摘	Small E J Schellhammer PF Higano CS	2006	J Clin Oncol2006，24，：	1
20	Overexpression of p53 in prostate carcinoma is associated with improved overall survival but not predictive of respone to radiotherapy显示文摘	Incognito LS Cazares LH Schellhammer PF	2000	Int J Oncol2000，17，4：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示